These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1685083)

  • 1. Effect of the ultrashort-acting beta-blocker Brevibloc on free-radical-mediated injuries during the early reperfusion state.
    Röth E; Török B
    Basic Res Cardiol; 1991; 86(5):422-33. PubMed ID: 1685083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Ca-antagonists, beta-blockers and antioxidant during reperfusion period.
    Röth E
    Bratisl Lek Listy; 1991; 92(3-4):195-200. PubMed ID: 2029661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the beta-blocker therapy on neutrophil superoxide generation and platelet aggregation in experimental myocardial ischemia and reflow.
    Röth E; Matos G; Guarnieri C; Papp B; Varga J
    Acta Physiol Hung; 1995; 83(2):163-70. PubMed ID: 8588503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of a novel thromboxane synthetase inhibitor, CV-4151, on myocardial damage due to coronary occlusion and reperfusion in the hearts of anesthetized dogs.
    Imamoto T; Terashita Z; Tanabe M; Nishikawa K; Hirata M
    J Cardiovasc Pharmacol; 1986; 8(4):832-9. PubMed ID: 2427826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary and systemic 6-ketoprostaglandin F1 alpha and thromboxane B2 during myocardial ischemia in dog.
    Prosdocimi M; Finesso M; Gorio A; Languino LR; Del Maschio A; Castagnoli MN; De Gaetano G; Dejana E
    Am J Physiol; 1985 Apr; 248(4 Pt 2):H493-9. PubMed ID: 3838623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced prostaglandin synthesis due to phospholipid breakdown in ischemic-reperfused myocardium. Control of its production by a phospholipase inhibitor or free radical scavengers.
    Otani H; Engelman RM; Rousou JA; Breyer RH; Das DK
    J Mol Cell Cardiol; 1986 Sep; 18(9):953-61. PubMed ID: 3097330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of cardiac sympathetic nerves on changes of TXB2 and 6-keto-PGF1 alpha in venous blood of ischemic myocardium].
    Zhao ZQ; Zang YM; Wang FZ; Li ZJ; Yang MF; Ma SY
    Sheng Li Xue Bao; 1989 Feb; 41(1):30-9. PubMed ID: 2762830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional differences in postischemic recovery in the stunned canine myocardium.
    Farber NE; Pieper GM; Gross GJ
    Am Heart J; 1987 Nov; 114(5):1086-95. PubMed ID: 3673875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free radical mediated injuries after coronary artery occlusion.
    Röth E; Török B; Kelemen D; Pollák S
    Basic Res Cardiol; 1989; 84(4):388-95. PubMed ID: 2818438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bisaramil on coronary-occlusion-reperfusion injury and free-radical-induced reactions.
    Paróczai M; Roth E; Matos G; Temes G; Lantos J; Karpati E
    Pharmacol Res; 1996 Jun; 33(6):327-36. PubMed ID: 8971954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cicletanine and reperfusion injury: is there any correlation between arrhythmias, 6-keto-PGF1 alpha, thromboxane B2, and myocardial ion shifts (Na+, K+, Ca2+, and Mg2+) induced by ischemia/reperfusion in isolated rat heart.
    Tosaki A; Hellegouarch A; Braquet P
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):551-9. PubMed ID: 1711620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arachidonic acid metabolism following aneurysm rupture. Evaluation of cerebrospinal fluid and serum concentration of 6-keto-prostaglandin F1 alpha and thromboxane B2 in patients with subarachnoid hemorrhage.
    Seifert V; Stolke D; Kaever V; Dietz H
    Surg Neurol; 1987 Mar; 27(3):243-52. PubMed ID: 3810456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise-induced increase in plasma arachidonic acid and thromboxane B2 in healthy men: effect of beta-adrenergic blockade.
    Laustiola K; Seppälä E; Nikkari T; Vapaatalo H
    J Cardiovasc Pharmacol; 1984; 6(3):449-54. PubMed ID: 6202971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotection during heart ischemia-reperfusion.
    Róth E; Lantos J; Temes G; Varga G; Paróczai M; Kárpáti E
    Acta Chir Hung; 1997; 36(1-4):306-9. PubMed ID: 9408384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imbalance between plasma levels of thromboxane B2 and 6-keto-prostaglandin F1 alpha during subacute endotoxin-induced hyperdynamic sepsis or multiple organ failure syndrome in sheep.
    Pittet JF; Morel DR
    Circ Shock; 1991 Oct; 35(2):65-77. PubMed ID: 1777948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of captopril cardioplegia on renin-angiotensin system, prostaglandins, free radicals and electrolytes in the isolated hypothermic ischemic and reperfusion rabbit hearts.
    Liu FM; Xu SC
    Chin Med J (Engl); 1993 Dec; 106(12):903-6. PubMed ID: 8143507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of prostacyclin and thromboxane A2 release during reperfusion after global ischemia induced by crystalloid cardioplegia--comparison between warm and cold ischemia.
    Nomura F; Matsuda H; Hirose H; Shirakura R; Ohtani M; Kaneko M; Kawashima Y
    Eur Surg Res; 1988; 20(2):110-9. PubMed ID: 3292253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a thromboxane A2 synthetase inhibitor on ventricular fibrillation threshold during coronary artery occlusion and reperfusion.
    Toda I; Nozaki A; Kawakubo K; Murakawa Y; Inoue H; Yoshimoto N; Sugimoto T
    Jpn Heart J; 1990 Jan; 31(1):87-97. PubMed ID: 2335849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of prostacyclin synthesis as a possible cause of transient flow reduction in a partially constricted canine coronary artery.
    Tada M; Esumi K; Yamagishi M; Kuzuya T; Matsuda H; Abe H; Uchida Y; Murao S
    J Mol Cell Cardiol; 1984 Dec; 16(12):1137-49. PubMed ID: 6398370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cicletanine on reperfusion-induced arrhythmias and its relation to 6-keto-PGF1 alpha and thromboxane B2 release.
    Tosaki A; Viossat I; Braquet P
    Can J Physiol Pharmacol; 1991 Apr; 69(4):488-93. PubMed ID: 2059911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.